Increased levels of α2-3-linked sialic acid have been detected on serum glycoproteins in patients with prostate cancer compared to benign prostatic hyperplasia (BPH), and can be used to predict Gleason score with a higher specificity and sensitivity than PSA [43,44]. Here, KLK3 is linked to prostate cancer.